Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure

Integrated Blood Pressure Control

Volumn 6, Issue , 2013, Pages 153-161

  Danyel, Leon A ^a   Schmerler, Patrick ^a   Paulis, Ludovit ^a,b,c   Unger, Thomas ^d   Steckelings, U Muscha ^a,e  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

AT2 receptor; Blood pressure; Kidney function; Renin angiotensin system; Vascular remodeling; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA AMINO ACID SUBSTITUTED ANGIOTENSIN II; COMPOUND 21; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; UNCLASSIFIED DRUG;

ARTERIAL STIFFNESS; BLOOD PRESSURE REGULATION; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; NATRIURESIS; NEPHRITIS; NONHUMAN; PROTEINURIA; REVIEW; VASOCONSTRICTION; VASODILATATION;

EID: 84888171158     PISSN: None     EISSN: 11787104     Source Type: Book Series    
DOI: 10.2147/IBPC.S34425     Document Type: Review

References (62)

1. Steckelings UM, Unger T. The renin-angiotensin-aldosterone system. In: Mancia G, Grassi G, Kjeldsen SE, editors. Manual of Hypertension of the European Society of Hypertension. 1st ed. London, UK: Informa Healthcare;2008:110-116.
2. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415-472.
3. Mentz RJ, Bakris GL, Waeber B, et al. The past, present and future of renin-angiotensin aldosterone system inhibition. Int J Cardiol. 2013;167(5):1677-1687.
4. Bader M, Santos RA, Unger T, Steckelings UM. New therapeutic pathways in the RAS. J Renin Angiotensin Aldosterone Syst. 2012;13(4): 505-508.
5. Ferreira AJ, Bader M, Santos RAS. Therapeutic targeting of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review. Expert Opin Ther Pat. 2012;22(5):567-574.
6. Steckelings UM, Paulis L, Unger T, Bader M. Emerging drugs which target the renin-angiotensin-aldosterone system. Expert Opin Emerg Drugs. 2011;16(4):619-630.
7. Ali Q, Wu Y, Hussain T. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int. Epub July 3, 2013.
8. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004;47(24):5995-6008.
9. Wagenaar GT, Laghmani el H, Fidder M, et al. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2013;305(5):L341-L351.
10. Jones ES, Del Borgo MP, Kirsch JF, et al. A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular function. Hypertension. 2011;57(3):570-576.
11. Dimitropoulou C, White RE, Fuchs L, Zhang H, Catravas JD, Carrier GO. Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca) channels. Hypertension. 2001;37(2):301-307.
12. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002;136(4):484-491.
13. Matrougui K, Lévy BI, Henrion D. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 2000;130(3):521-526.
14. Matrougui K, Loufrani L, Heymes C, Lévy BI, Henrion D. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension. 1999;34(4 Pt 1):659-665.
15. Widdop RE, Matrougui K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension. 2002;40(4):516-520.
16. Arima S, Endo Y, Yaoita H, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1997;100(11):2816-2823.
17. Endo Y, Arima S, Yaoita H, et al. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int Suppl. 1997;63:S205-S207.
18. Endo Y, Arima S, Yaoita H, Tsunoda K, Omata K, Ito S. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res. 1998;35(6): 421-427.
19. Batenburg WW, Garrelds IM, Bernasconi CC, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation. 2004;109(19):2296-2301.
20. Haberl RL. Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke. 1994;25(7):1476-1479;discussion 1480.
21. Savoia C, Touyz RM, Volpe M, Schiffrin EL. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension. 2007;49(2):341-346.
22. Pulgar VM, Yamashiro H, Rose JC, Moore LG. Role of the AT2 receptor in modulating the angiotensin-II contractile response of the uterine artery at mid gestation. J Renin Angiotensin Aldosterone Syst. 2011;12(3):176-183.
23. Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol. 2003;140(5): 809-824.
24. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 1995;377(6551):744-747.
25. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377(6551):748-750.
26. Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104(7):925-935.
27. Bosnyak S, Welungoda IK, Hallberg A, Alterman M, Widdop RE, Jones ES. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol. 2010;159(3):709-716.
28. Verdonk K, Durik M, Abd-Alla N, et al. Compound 21 induces vasorelaxation via an endothelium-and angiotensin II type 2 receptor-independent mechanism. Hypertension. 2012;60(3):722-729.
29. Baker JG. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2-and beta3-adrenoceptors. Br J Pharmacol. 2010;160(5): 1048-1061.
30. Griffin PP, Schubert-Zsilavecz M, Stark H. [Inhibitors of beta-adrenergic receptors: Similarities and differences] Hemmstoffe von beta-Adrenozeptoren: Gemeinsamkeiten und Unterschiede. Pharmazie in Unserer Zeit. 2004;33(6):442-449. German.
31. Carey RM, Howell NL, Jin XH, Siragy HM. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension. 2001;38(6):1272-1277.
32. Barber MN, Sampey DB, Widdop RE. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension. 1999;34(5):1112-1116.
33. Efrati S, Berman S, Abu Hamad R, et al. Hyperglycaemia, inflammation, RAS activation: three culprits to blame for acute kidney injury emerging in healthy rats during general anaesthesia. Nephrology (Carlton). 2012;17(7):591-602.
34. Carey RM, Padia SH. Role of angiotensin at(2) receptors in natriuresis: intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol. 2013;40(8):527-534.
35. Hilliard LM, Jones ES, Steckelings UM, Unger T, Widdop RE, Denton KM. Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension. 2012;59(2):409-414.
36. Ali Q, Hussain T. AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. Hypertens Res. 2012;35(6):654-660.
37. Gao J, Zhang H, Le KD, Chao J, Gao L. Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am J Hypertens. 2011;24(6):724-730.
38. August P, Lenz T, Ales KL, et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol. 1990;163(5 Pt 1):1612-1621.
39. Anton L, Merrill DC, Neves LA, et al. The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy. Endocrinology. 2009;150(9):4316-4325.
40. Anton L, Merrill DC, Neves LA, et al. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension. 2008;51(4):1066-1072.
41. McMullen JR, Gibson KJ, Lumbers ER, Burrell JH. Selective down-regulation of AT2 receptors in uterine arteries from pregnant ewes given 24-h intravenous infusions of angiotensin II. Regul Pept. 2001;99(2-3):119-129.
42. Hladunewich MA, Kingdom J, Odutayo A, et al. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab. 2011;96(11): 3517-3524.
43. Schmieder RE. End organ damage in hypertension. Dtsch Arztebl Int. 2010;107(49):866-873.
44. Jones ES, Black MJ, Widdop RE. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. J Mol Cell Cardiol. 2004;37(5):1023-1030.
45. Tea BS, Der Sarkissian S, Touyz RM, Hamet P, deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension. 2000;35(5):1069-1073.
46. Akishita M, Iwai M, Wu L, et al. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation. 2000;102(14):1684-1689.
47. Brede M, Hadamek K, Meinel L, et al. Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation. 2001;104(21):2602-2607.
48. Wu L, Iwai M, Nakagami H, et al. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol. 2002;22(1):49-54.
49. Paulis L, Becker ST, Lucht K, et al. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension. 2012;59(2):485-492.
50. Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension. 2012;59(2):291-299.
51. Benndorf RA, Krebs C, Hirsch-Hoffmann B, et al. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int. 2009;75(10):1039-1049.
52. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 1998;53(4):937-944.
53. Chang S-Y, Chen Y-W, Chenier I, Tran SLM, Zhang S-L. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp Diabetes Res. 2011;2011:521076.
54. Jöhren O, Dendorfer A, Dominiak P. Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res. 2004;62(3): 460-467.
55. Wenzel UO, Krebs C, Benndorf R. The angiotensin II type 2 receptor in renal disease. J Renin Angiotensin Aldosterone Syst. 2010;11(1): 37-41.
56. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95(2):651-657.
57. 2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension. 2011;57(2):308-313.
58. Gelosa P, Pignieri A, Fändriks L, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens. 2009;27(12):2444-2451.
59. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation. 2008;118(24): 2523-2532.
60. Jing F, Mogi M, Sakata A, et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab. 2012;32(2):248-255.
61. Dhande I, Ali Q, Hussain T. Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension. 2013;61(6):1218-1226.
62. Ohshima K, Mogi M, Jing F, et al. Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation. PLoS One. 2012;7(11):e48387.